[Federal Register Volume 61, Number 222 (Friday, November 15, 1996)] [Notices] [Page 58574] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-29343] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Environmental Health Sciences; Notice of a Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Institute of Environmental Health Sciences Special Emphasis Panel (SEP) meeting: Name of SEP: SBIR Phase II Topic 34--High Affinity, Inhibitory Antibodies to Human Cytochromes P450. Date: November 26, 1996. Time: 9:00 a.m. EST. Place: National Institute of Environmental Health Sciences North Campus, Building 17 Conference Room 1713 Research Triangle Park, NC. Contact Person: Dr. John Braun, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709, (919) 541-1446. Purpose/Agenda: To review and evaluate contract proposals. The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. This notice is being published less than fifteen days prior to this meeting due to the urgent need to meet timing limitations imposed by the contract review and funding cycle. (Catalog of Federal Domestic Assistance Programs Nos. 93.113, Biological Response to Environmental Agents; 93.114, Applied Toxicological Research and Testing; 93.115, Biometry and Risk Estimation; 93.894, Resource and Manpower Development, National Institutes of Health.) Paula N. Hayes, Acting Committee Management Officer, NIH. [FR Doc. 96-29343 Filed 11-14-96; 8:45 am] BILLING CODE 4140-01-M